NEPA <scp>(</scp>Netupitant/Palonosetron) for the Prevention of Chemotherapy‐Induced Nausea and Vomiting (<scp>CINV</scp>) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough <scp>CINV</scp> in Cycle 1 of C

Authors

Rudolph M. Navari (ORCID: https://orcid.org/0000-0002-8513-896X)
Erminio Bonizzoni

Institutions

University of Mount Olive (US)

Publication Details

Journal: Cancer Medicine
Published: 2025-03-27
DOI: https://doi.org/10.1002/cam4.70549
Citations: 1
Primary Topic: Nausea and vomiting management
Type: article
Field-Weighted Citation Impact: 2.01

Funders

Helsinn Therapeutics

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of C

Rudolph M. Navari, Erminio Bonizzoni

Mar 27, 2025

1 citations

Cancer Medicine

Nausea and vomiting management

2.01

article

NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of C

Rudolph M. Navari, Erminio Bonizzoni

March 27, 2025article en

1 citations

Abstract

No abstract available for this paper.

Cancer MedicineVol. 14(7)

University of Mount Olive (US)

Helsinn Therapeutics

Openalex Percentile: Top 17%

Nausea and vomiting management

2.01

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

NEPA <scp>(</scp>Netupitant/Palonosetron) for the Prevention of Chemotherapy‐Induced Nausea and Vomiting (<scp>CINV</scp>) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough <scp>CINV</scp> in Cycle 1 of C — Rudolph M. Navari, Erminio Bonizzoni · Cancer Medicine (2025) | TGRS Research Map | TGRS